EVAN MINKOFF: Open Payments
NPI 1831150739 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 34 payments from 7 companies in 2025. Trend: 2023 $756 · 2024 $520 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 19 | $410 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $143 |
| Virtus Pharmaceuticals LLC | 2 | $63 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $48 |
| SCILEX PHARMACEUTICALS INC. | 2 | $37 |
| Forte Bio-Pharma LLC | 1 | $23 |
| Valinor Pharma, LLC | 1 | $19 |
Products named: Belbuca, RELISTOR, LEVORPHANOL TARTRATE, JOURNAVX, ZTLido, PROLATE, MOVANTIK.
Industry payments across CA — which companies pay providers there.
